Prescriby: A Beacon of Hope in the Opioid Crisis

Icelandic-Canadian biotech startup, Prescriby, has secured €2 million in funding to combat the opioid crisis with its innovative addiction management platform. The Prescriby app, developed by CEO Dr. Kjartan Thorsson, allows patients to taper down their addictive medication under the guidance of clinicians through personalized tapering plans. This remote monitoring system aims to provide a safer and more effective approach to addiction management. With the support of investors from Nordic countries, Canada, Denmark, and Iceland, Prescriby is set to scale its operations in Canada and enter the US market as a clinical decision support tool for prescription opioids. Dr. Thorsson's firsthand experience in managing post-operative patients at the University Hospital of Iceland inspired the creation of Prescriby, as he witnessed the devastating impact of opioid addiction firsthand. By focusing on early intervention and prevention, Prescriby is poised to make a significant impact in the fight against opioid addiction.